Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2017, Article ID 1671607, 6 pages
https://doi.org/10.1155/2017/1671607
Review Article

Roles of Interferons in Pregnant Women with Dengue Infection: Protective or Dangerous Factors

1Department of Infectious Diseases, The Key Discipline of Guangdong Province, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, No. 151 Yanjiang Road, Guangdong Province 510120, China
2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, No. 151 Yanjiang Road, Guangdong Province 510120, China
3Guangdong Provincial Key Laboratory of Tropical Disease Research and Key Laboratory of Prevention and Control for Emerging Infectious Diseases of Guangdong Higher Institutes, School of Public Health and Tropical Medicine, Southern Medical University, No. 1023 South Shatai Road, Guangzhou, Guangdong Province 510515, China

Correspondence should be addressed to Wenting Zeng; moc.361@55854690631 and Hong-Juan Peng; nc.ude.ums@naujgnoh

Received 15 June 2017; Revised 1 August 2017; Accepted 6 August 2017; Published 7 September 2017

Academic Editor: Maria L. Tornesello

Copyright © 2017 Hao Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. J. Brady, P. W. Gething, S. Bhatt et al., “Refining the global spatial limits of dengue virus transmission by evidence-based consensus,” PLoS Neglected Tropical Diseases, vol. 6, no. 8, Article ID e1760, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Bhatt, P. W. Gething, O. J. Brady et al., “The global distribution and burden of dengue,” Nature, vol. 496, no. 7446, pp. 504–507, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. P. Simmons, J. J. Farrar, N. van Vinh Chau, and B. Wills, “Dengue,” The New England Journal of Medicine, vol. 366, no. 15, pp. 1423–1432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H. O. World, P. F. R. Special, I. T. D. Training, H. O. D. O. World, H. O. E. World, and A. Pandemic, Dengue: guidelines for diagnosis, treatment, prevention and control, guidelines for diagnosis, Dengue, 2009.
  5. P. Boeuf, H. E. Drummer, J. S. Richards, M. J. L. Scoullar, and J. G. Beeson, “The global threat of Zika virus to pregnancy: Epidemiology, clinical perspectives, mechanisms, and impact,” BMC Medicine, vol. 14, no. 1, article no. 112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Marrs, G. Olson, G. Saade et al., “Zika Virus and Pregnancy: A Review of the Literature and Clinical Considerations,” American Journal of Perinatology, vol. 33, no. 7, pp. 625–639, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. N. A. Mohamed Ismail, W. E. R. Wan Abd Rahim, S. A. Salleh, H.-M. Neoh, R. Jamal, and M. A. Jamil, “Seropositivity of dengue antibodies during pregnancy,” Scientific World Journal, vol. 2014, Article ID 436975, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Laoprasopwattana, T. Suntharasaj, P. Petmanee, O. Suddeaugrai, and A. Geater, “Chikungunya and dengue virus infections during pregnancy: Seroprevalence, seroincidence and maternal-fetal transmission, southern Thailand, 2009-2010,” Epidemiology and Infection, vol. 144, no. 2, pp. 381–388, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. T.-Y. Yen, M. D. J. Trovoada dos Santos, L.-F. Tseng et al., “Seroprevalence of antibodies against dengue virus among pregnant women in the Democratic Republic of Sao Tome and Principe,” Acta Tropica, vol. 155, pp. 58–62, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Adam, A. M. Jumaa, H. M. Elbashir, and M. S. Karsany, “Maternal and perinatal outcomes of dengue in PortSudan, Eastern Sudan,” Virology Journal, vol. 7, article no. 153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. R. Machado, E. S. Machado, R. Denis Rohloff et al., “Is Pregnancy Associated with Severe Dengue? A Review of Data from the Rio de Janeiro Surveillance Information System,” PLoS Neglected Tropical Diseases, vol. 7, no. 5, Article ID e2217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. E. S. Paixão, M. G. Teixeira, M. D. C. N. Costa, and L. C. Rodrigues, “Dengue during pregnancy and adverse fetal outcomes: A systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 16, no. 7, pp. 857–865, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Zavattoni, F. Rovida, G. Campanini et al., “Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016,” Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, vol. 21, no. 31, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. S. R. Paludan, “Innate Antiviral Defenses Independent of Inducible IFNα/β Production,” Trends in Immunology, vol. 37, no. 9, pp. 588–596, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Allen and K. H. Fantes, “A family of structural genes for human lymphoblastoid (leukocyte-type) interferon,” Nature, vol. 287, no. 5781, pp. 408–411, 1980. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Karpusas, M. Nolte, C. B. Benton, W. Meier, W. N. Lipscomb, and S. Goelz, “The crystal structure of human interferon at 2.2-A resolution,” Proceedings of the National Academy of Sciences, vol. 94, no. 22, pp. 11813–11818, 1997. View at Publisher · View at Google Scholar
  17. S. E. Ealick, W. J. Cook, S. Vijay-Kumar et al., “Three-dimensional structure of recombinant human interferon-γ,” Science, vol. 252, no. 5006, pp. 698–702, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. S. V. Kotenko, G. Gallagher, V. V. Baurin et al., “IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex,” Nature Immunology, vol. 4, no. 1, pp. 69–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. D. S. Oliveira, M. M. C. da Silva, C. E. Calzavara-Silva et al., “Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase,” Memorias do Instituto Oswaldo Cruz, vol. 111, no. 6, pp. 378–384, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. S. I. De La Cruz Hernández, H. Puerta-Guardo, H. Flores-Aguilar et al., “A strong interferon response correlates with a milder dengue clinical condition,” Journal of Clinical Virology, vol. 60, no. 3, pp. 196–199, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Becquart, N. Wauquier, D. Nkoghe et al., “Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production,” BMC Infectious Diseases, vol. 10, article no. 356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Pandey, A. Jain, R. K. Garg, R. Kumar, O. P. Agrawal, and P. V. Lakshmana Rao, “Serum levels of IL-8, IFNγ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection,” Archives of Virology, vol. 160, no. 6, pp. 1463–1475, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. R. N. M. Feitosa, A. C. R. Vallinoto, P. F. D. C. Vasconcelos et al., “Gene Polymorphisms and Serum Levels of Pro- and Anti-Inflammatory Markers in Dengue Viral Infections,” Viral Immunology, vol. 29, no. 7, pp. 379–388, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Zhao, X. Huang, W. Hong et al., “Slow resolution of inflammation in severe adult dengue patients,” BMC Infectious Diseases, vol. 16, no. 1, article no. 291, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Cui, Y. H. Lee, T. L. Thein et al., “Serum Metabolomics Reveals Serotonin as a Predictor of Severe Dengue in the Early Phase of Dengue Fever,” PLoS Neglected Tropical Diseases, vol. 10, no. 4, Article ID e0004607, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-L. Hsu, M.-Y. Wang, L.-J. Ho, and J.-H. Lai, “Dengue virus infection induces interferon-lambda1 to facilitate cell migration,” Scientific Reports, vol. 6, Article ID 24530, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. H. K. Palma-Ocampo, J. C. Flores-Alonso, V. Vallejo-Ruiz et al., “Interferon lambda inhibits dengue virus replication in epithelial cells,” Virology Journal, vol. 12, no. 1, article no. 150, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Priyadarshini, R. R. Gadia, A. Tripathy et al., “Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study,” PLoS ONE, vol. 5, no. 1, Article ID e8709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Pal, S. K. Dutta, S. Mandal, B. Saha, and A. Tripathi, “Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level,” Journal of Clinical Virology, vol. 61, no. 3, pp. 365–370, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. L. St John, A. P. S. Rathore, B. Raghavan, M.-L. Ng, and S. N. Abraham, “Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage,” eLife, vol. 2013, no. 2, Article ID e00481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. O. Pozo-Aguilar, V. Monroy-Martínez, D. Díaz et al., “Evaluation of host and viral factors associated with severe dengue based on the 2009 WHO classification,” Parasites & Vectors, vol. 7, no. 1, p. 590, 2014. View at Publisher · View at Google Scholar
  32. W.-K. Wang, D.-Y. Chao, C.-L. Kao et al., “High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis,” Virology, vol. 305, no. 2, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. F. W. Bazer, T. E. Spencer, G. A. Johnson, R. C. Burghardt, and G. Wu, “Comparative aspects of implantation,” Reproduction, vol. 138, no. 2, pp. 195–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. E. Spencer, O. Sandra, and E. Wolf, “Genes involved in conceptus-endometrial interactions in ruminants: Insights from reductionism and thoughts on holistic approaches,” Reproduction, vol. 135, no. 2, pp. 165–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Kim, H. Seo, Y. Choi, J. Shim, F. W. Bazer, and H. Ka, “Swine leukocyte antigen-DQ expression and its regulation by interferon-gamma at the maternal-fetal interface in pigs,” Biology of Reproduction, vol. 86, no. 2, article no. 43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Joyce, J. R. Burghardt, R. C. Burghardt, R. N. Hooper, F. W. Bazer, and G. A. Johnson, “Uterine MHC class I molecules and β2-microglobulin are regulated by progesterone and conceptus interferons during pig pregnancy,” Journal of Immunology, vol. 181, no. 4, pp. 2494–2505, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. L. J. Yockey, L. Varela, T. Rakib et al., “Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain Infection,” Cell, vol. 166, no. 5, pp. 1247–1256.e4, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Bayer, N. J. Lennemann, Y. Ouyang et al., “Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection,” Cell Host and Microbe, vol. 19, no. 5, pp. 705–712, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Uçar, T. Ertekin, M. Nisari, D. Ceylan, Ö. Al, and H. Ülger, “The potential teratogenic effects of interferon beta-1a and interferon beta-1b on in vitro embryonic development,” Folia Morphologica (Poland), vol. 75, no. 2, pp. 257–263, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Li, Z. Song, C. Meng, D. Yang, Y. Yang, and J. Peng, “IFN-γ modulates Ly-49 receptors on NK cells in IFN-γ-induced pregnancy failure,” Scientific Reports, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  41. A. U. Borbely, J. D. Fontenele-Neto, A. K. Vidsiunas et al., “Ectoplacental cone induces resistance to apoptosis in high doses of interferon (IFN)-γ-treated decidual cells,” American Journal of Reproductive Immunology, vol. 67, no. 1, pp. 73–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Chistyakova, I. Gazieva, I. Remizova, L. Ustyantseva, V. Lyapunov, and S. Bychkova, “Risk factors vary early preterm birth and perinatal complications after assisted reproductive technology,” Gynecological Endocrinology, vol. 32, pp. 56–61, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Giles, K. Visvanathan, and J. Sasadeusz, “Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding,” Antiviral Therapy, vol. 16, no. 5, pp. 621–628, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Boskovic, R. Wide, J. Wolpin, D. J. Bauer, and G. Koren, “The reproductive effects of beta interferon therapy in pregnancy: A Longitudinal Cohort,” Neurology, vol. 65, no. 6, pp. 807–811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Liu, Y. Chen, Y. Yang, and J.-P. Peng, “The effect on MHC class II expression and apoptosis in placenta by IFNγ administration,” Contraception, vol. 65, no. 2, pp. 177–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Chaouat, E. Menu, D. A. Clark, M. Dy, M. Minkowski, and T. G. Wegmann, “Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy,” Journal of Reproduction and Fertility, vol. 89, no. 2, pp. 447–458, 1990. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Yui, M. Garcia-Lloret, T. G. Wegmann, and L. J. Guilbert, “Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts,” Placenta, vol. 15, no. 8, pp. 819–835, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. R. S. Berkowitz, J. A. Hill, C. B. Kurtz, and D. J. Anderson, “Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro,” American Journal of Obstetrics and Gynecology, vol. 158, no. 1, pp. 199–203, 1988. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Zhang, M. Zhao, F. Jiao et al., “Interferon gamma is involved in apoptosis of trophoblast cells at the maternal-fetal interface following Toxoplasma gondii infection,” International Journal of Infectious Diseases, vol. 30, pp. e10–e16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Comba, E. Bastu, O. Dural et al., “Role of inflammatory mediators in patients with recurrent pregnancy loss,” Fertility and Sterility, vol. 104, no. 6, pp. 1467–1474.e1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Li, J. Tu, Y. Jiang, J. Zhou, and D. J. Schust, “Regulatory T cells decrease invariant natural killer T cell-mediated pregnancy loss in mice,” Mucosal Immunology, vol. 10, no. 3, pp. 613–623, 2016. View at Publisher · View at Google Scholar
  52. K. Okkenhaug, “Signaling by the phosphoinositide 3-kinase family in immune cells,” Annual Review of Immunology, vol. 31, pp. 675–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Guo, A. Samarakoon, B. Vanhaesebroeck, and S. Malarkannan, “The p110δ of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation,” Journal of Experimental Medicine, vol. 205, no. 10, pp. 2419–2435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Saudemont, F. Garçon, H. Yadi et al., “p110γ and p110δ isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5795–5800, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Kieckbusch, E. Balmas, D. A. Hawkes, and F. Colucci, “Disrupted PI3K p110δ Signaling Dysregulates Maternal Immune Cells and Increases Fetal Mortality In Mice,” Cell Reports, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. W.-X. Zhao and J.-H. Lin, “Notch signaling pathway and human placenta,” International Journal of Medical Sciences, vol. 9, no. 6, pp. 447–452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. M. K. Jaiswal, V. Agrawal, S. Pamarthy et al., “Notch Signaling in Inflammation-Induced Preterm Labor,” Scientific Reports, vol. 5, no. 1, 2015. View at Publisher · View at Google Scholar